Detection of Methicillin-resistant and Biofilm-producing Staphylococcus aureus in Bovine Mastitis by Hamed, Maha Ibrahim
Introduction
Staphylococcus aureus (S. aureus) has been identified as a
major source of bovine clinical and subclinical mastitis
(Szweda et al., 2012; Cervinkova et al., 2013). In recent years,
methicillin-resistant S. aureus (MRSA) strains have been in-
creasingly reported as an emerging crisis in bovine mastitis
cases making this disease very challenging to treat (Vander-
haeghen et al., 2010; Saini et al., 2012; Zutic et al., 2012).  Fur-
thermore, cows with subclinical mastitis may act as a source
of infection for other animals, resulting in the spread of mas-
titis infection to the rest of the herd (Sharma et al., 2015).
Sayed (2014) investigated the problem of clinical mastitis in
dairy cows within the Assiut Governorate, Egypt and found
that S. aureus was the main causative agent (34.65%) with 60%
of these isolates identified as MRSA. To ensure suitable antibi-
otic treatment, bacterial isolation and evaluation of antibiotic
susceptibility are necessary. Early and specific antibiotic treat-
ment can reduce the severity of the disease. However, exten-
sive use of antibiotics over the years has contributed to an
increase in antibiotic resistance. Although S. aureus is suscep-
tible to a variety of antibiotics in vitro, treatment of intra-mam-
mary infections results in a low cure rate, regardless of the
antibiotic used (Keefe, 2012). This may be a result of incom-
plete penetration of the antibiotics throughout the gland and
the potential survival of bacteria within host cells, leading to
a recurrence of mastitis once treatment has ended (Hebert et
al., 2000; Kerr et al., 2001; Barcia-Macay et al., 2006). Another
contributing factor to the recurrence of mastitis may be due
to the formation of biofilms (slime) that are resistant to the ef-
fect of many antibiotics (Cramton et al., 1999). The majority of
S. aureus strains causing mastitis are surrounded by a slime
layer, which helps bacteria to attach and colonize the mam-
mary gland tissue (Baselga et al., 1993; Aguilar et al., 2001).
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aureus in Bovine Mastitis
Maha I. Hamed
The present study was employed to investigate the causative microorganisms responsible for clinical
and subclinical mastitis and their antibiotic susceptibility pattern on a private cow farm in Assiut Gov-
ernorate, Egypt, where a history of recurrent mastitis was the main complaint. In addition, the isolates
were investigated for their ability to form biofilm. Forty cows were subjected to a physical examination
of the udder and milk using the California mastitis test. Additionally, milk sample collections were ob-
tained, and bacterial specimens were isolated and evaluated for the presence of the mecA gene by PCR.
Antibacterial susceptibility assays against the common antibiotics used in the veterinary field were con-
ducted for all isolates obtained. Furthermore, biofilm production by bacterial isolates was detected
using the microtiter plate method and the activity of specific antibiotics was evaluated against pre-
formed biofilms. About 10% of the examined cows showed clinical signs of mastitis, and 22.2% revealed
subclinical mastitis infection when evaluated via the California mastitis test. Staphylococcus aureus was
isolated from all mastitic cows, which indicated that it was the main causative organism for the infection.
Streptococcus spp. were isolated from six mastitic animals. Half of the S. aureus isolates were methi-
cillin-resistant, and 83.33% of them were capable of producing biofilm. All Streptococcus spp. isolates
were sensitive to all the antibiotics evaluated in the study. S. aureus isolates in the planktonic form were
resistant to oxytetracycline and penicillin. In contrast, S. aureus encased in biofilm were resistant to all
the antibiotics used in the study. This research detected highly-virulent S. aureus isolates from clinical
and subclinical mastitic cases that carry the mecA gene and produce biofilm. The owner is advised to
cull the diseased cows to prevent the spread of these virulent isolates to healthy animals. Also, it is ad-
visable not to treat the diseased cows with the antibiotics evaluated in this study as they were found
to be ineffective and may potentially contribute to persistence of the infection.
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The ability of S. aureus to bind to epithelial surfaces is associ-
ated with the production of a biofilm composed of multilay-
ered cell clusters embedded in a slime matrix (Cucarella et al.,
2001). Biofilm formation is associated with antimicrobial re-
sistance because of the difficulty antibiotics have in diffusing
through the polysaccharide matrix and reduced metabolic ac-
tivity of bacteria within the biofilm (Amorena et al., 1999; Mel-
chior et al., 2006; Yazdani et al., 2006). In Egypt, research on
bacterial biofilms has only begun recently and mainly focused
on S. aureus isolates from human sources (Gad et al., 2009;
Nasr et al., 2012). The present study was designed to investi-
gate the causative microorganisms responsible of bovine mas-
titis and their antibiotic susceptibility pattern on a private cow
farm in Assiut Governorate, Egypt. The owner of the farm com-
plained of recurrent mastitis in his herd that did not respond
to different treatment options. One of the most common
causes of failure in therapy is the ability of the causative bac-
teria to grow in biofilm. So, the study was aimed at also inves-
tigating the biofilm-forming ability of bacterial isolates that
were the source of mastitis in these cows.
Materials and methods
Examination for mastitis
The study was conducted on a private cow farm (40 cows
in total) within Assiut Governorate, Egypt, where a history of
recurrent clinical mastitis in cows was the chief complaint.
Some cases of mastitis responded to treatment with Tetra-
Delta intra-mammary infusion (procaine penicillin and
neomycin) for a few days before signs of mastitis reappeared
again. In certain cases, diseased cows did not respond to the
treatment at all. The cases of clinical mastitis were diagnosed
based on history, clinical signs, and physical examination of
udder and milk. Cases of subclinical mastitis were diagnosed
using the California mastitis test (Schalm et al., 1971).
Sample collection and bacterial isolation
Milk samples were collected from all quarters of cows with
clinical mastitis and subclinical mastitis (as identified by the
California mastitis test). Udders of cows presenting with mas-
titis were washed with clean water and dried. Cotton swabs
soaked with 70% ethanol were used to disinfect the surfaces
of teats. The first few streams of milk were discarded before a
milk sample was collected into a 10-ml sterile plastic tube.
Samples were sent directly to the laboratory in an ice tank and
cultured on the same day of sample collection. Milk samples
were inoculated on 5% sheep blood agar plates and incubated
at 37ºC for 24 h. S. aureus identification was confirmed via
gram staining, colony morphology, and traditional biochemi-
cal tests, including catalase, coagulase and mannitol fermen-
tation tests (Turk and Porter, 1978; Bannerman, 2003). Other
pathogens were identified using laboratory procedures that
followed the guidelines defined by the National Mastitis
Council (NMC, 1999).
Detection of mecA gene
DNAs from S. aureus isolates were extracted using the
DNAeasy Tissue Kit (QIAamp® DNA Mini Kit) with some mod-
ifications to the manufacturer’s protocol. The extracted DNA
was used as a template for PCR amplification. PCR amplifica-
tions were performed with a pair of primers specific for the
mecA gene, synthesized from the previously published se-
quences: primer 1: 5'-AAA ATC GAT GGT AAA GGT TGG C-3',
primer 2: 5'-AGT TCT GCA GTA CCG GAT TTG C-3' (Louie et al.,
2002). The PCR cycles consisted of initial denaturation at 96°C
for 5 min, followed by 40 cycles of denaturation at 95°C for
30s, annealing at 60°C for 30s, and extension at 72°C for 1 min,
and final extension at 72°C for 10 min. The PCR products were
analyzed by electrophoresis in a 1.5% agarose gel containing
0.5 mg of ethidium bromide per ml. The sizes of the amplifi-
cation products were estimated by comparison with a 100bp
DNA step ladder.
Antibacterial assays
The selected antimicrobial agents (oxytetracycline, peni-
cillin, clindamycin, ciprofloxacin, marbofloxacin, levofloxacin,
vancomycin, ceftriaxone and enrofloxacin) were provided as
powders by VWR, USA. The antimicrobial agents were subse-
quently dissolved in suitable solvents to make stock 10µg/ml
solutions. The minimum inhibitory concentration (MIC) of
each antibiotic was evaluated using the broth microdilution
technique, in Mueller-Hinton broth (MHB), in accordance with
the Clinical and Laboratory Standards Institute’s (CLSI) guide-
lines (CLSI, 2007). The MIC was interpreted as the lowest con-
centration of antibiotic that completely inhibited the growth
of bacteria after 16 h incubation of the plates at 37°C. Each
agent was tested in triplicate in at least two independent ex-
periments. The highest MIC value for each test agent was re-
ported.
Detection of biofilm by Microtiter plate method (MTP)
The ability of S. aureus isolates to form biofilm was inves-
tigated by a method described by Stepanovic et al. (2007) with
some modifications. Bacteria were cultivated overnight in
Tryptic Soy Broth (TBS) supplemented with 1% glucose. Each
culture was diluted 1:100 in the same medium and, subse-
quently, 200 μl of the diluted bacterial suspension was trans-
ferred, in triplicates, into the wells of sterile 96-well
polystyrene microtiter plates and incubated at 37°C for 24 h.
The negative control contained only the growth medium. The
plates were washed twice with 200 μl of PBS (pH 7.2) and dried
at room temperature prior to staining biofilms with 1% crystal
violet. The plates were incubated at room temperature for 15
min before excess dye was removed by washing with water.
The biofilm-bound dye was dissolved in 150 μl of 95% ethanol
(SIGMA-ALDRICH Ethanol Lot # SZBE1180V Germany
UN1170). The OD of dye (representing biofilm density) was
measured at 595-nm by using a microplate reader (Spectra
Max i3x, 363701003).
Antibiotic activity against preformed biofilms
The activity of antibiotics against 24 h-old biofilms was as-
sessed by viable colony count. Biofilms were allowed to form
in each well of a 96-well flat-bottom polystyrene tissue cul-
ture-treated microtiter plate (Becton, Dickinson and Com-
pany), as described above. Following 24 h-incubation, biofilms
were washed twice with PBS, then exposed to 200 μl of drug-
containing cation-adjusted Mueller–Hinton broth (CAMHB)
(prepared with 1, 2, 4, 8, 16, 32, 64, and 128 × MIC of antibi-
otics). After incubation at 37 °C for 24 h, non-adherent bacte-
ria were removed by washing twice with 200 μl sterile PBS, and
biofilm samples were scraped as described above. The cell
suspension was then vortexed for 1 min to break up bacterial
clumps. Bacterial counts were performed by plating serial 10-
fold dilutions of this suspension on MHA plates. Control
biofilm samples were not exposed to antibiotics. The Mini-
mum Biofilm Eradication Concentration (MBEC) was catego-
rized as the minimum concentration of tested antibiotic able
to completely eradicate mature biofilm.
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Results
Examination results
Physical examination of the udder and milk identified four
cows out of 40 (10%) with clinical mastitis, which were unsuc-
cessfully treated with Tetra-Delta intra-mammary infusion. Ex-
amination of clinically healthy cows (n.=36) using the
California mastitis test revealed eight cows with subclinical
mastitis (22.2%). 
Bacteriology results
S. aureus was isolated from all 12 mastitic milk samples.
Furthermore, Streptococcus spp. were isolated from six mastitic
milk samples only (all four samples from clinical mastitic cows
and two samples from subclinical mastitic cows).
mecA gene detection results
Of the 12 S. aureus isolates obtained from the mastitic
cows, six isolates were mecA gene positive (MRSA) and the
other six isolates were negative. The PCR product of MRSA
isolates revealed a positive band at 533bp on the agarose gel
electrophoresis (Fig. 1).
Antibacterial assay results
The Streptococcus spp. isolates were sensitive to all the an-
tibiotic evaluated via the broth microdilution assay. S. aureus
isolates in the planktonic form were also sensitive to all an-
tibiotics used in the assay except for oxytetracycline and peni-
cillin (Table 1).
Detection of biofilm results
All six MRSA isolates were capable of producing a biofilm
on the 96-well polystyrene microtiter plates. Meanwhile, only
four isolates of mecA negative S. aureus could form a biofilm.
Thus, 10 out of 12 S. aureus isolates were found to be capable
of forming a biofilm. As shown in Fig. 2, crystal violet dye
bound to the bacteria adhered to the bottom of the wells in-
dicating biofilm formation.
Results of antibiotic activity against preformed biofilms
The MBEC of antibiotics against S. aureus and MRSA iso-
lates ranged from 8 to >128 µg/ml, which indicates that bac-
teria present within the biofilm are resistant to the antibiotics
evaluated (Table 2).
Fig. 1. Agarose gel showing PCR products of mecA positive S. au-
reus isolates from mastitis cases (positive band at 533 bp). M =
Marker, lane (+) = positive control, lane (-) = negative control, lane
(1,3,4) = positive samples and lane (2) = negative sample.
Table 1. Antimicrobial susceptibility pattern of Streptococcus spp. and S. aureus isolated from mastitic milk samples using
the broth microdilution technique.
Fig. 2. Microtiter plates showing S. aureus biofilm producing iso-
lates differentiated by crystal violet staining in 96-well tissue culture
plates, a. negative and b. wells with biofilm.
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Discussion
Mastitis affects dairy cows on every dairy farm in Egypt.
In particular, contagious mastitis caused by S. aureus, is a
costly and critical problem in the dairy industry. Treatment and
eradication of S. aureus in mastitis cases is difficult, because
of the frequent emergence of bacterial resistance to antimi-
crobials. Recently, an increasing rate of antimicrobial resistance
has been identified in S. aureus strains isolated from bovine
mastitis (Saini et al., 2012; Wang et al., 2013). This is generally
attributed to misuse and/or continuous use of antibacterial
drugs without prior drug susceptibility testing or to the colo-
nization of the mammary gland by resistant strains. These an-
timicrobial resistant organisms can induce serious health
problems to both animals and human beings.
In the present study of 40 cows on one dairy farm in Egypt,
S. aureus was isolated from all 12 cows presenting with mas-
titis. Meanwhile, Streptococcus spp. was isolated only from four
cases, which indicates that S. aureus is the main causative
pathogen of mastitis in the examined cows. This is in agree-
ment with other published reports (Sumathi et al., 2008; Singh
et al., 2016) that found a higher prevalence of Staphylococcus
spp. in the milk of cows with mastitis. Moreover, Moroni et al.
(2006) stated in their report that S. aureus was frequently iso-
lated in bovine clinical and subclinical mastitis.
Half (50%) of the S. aureus strains isolated from mastitic
milk in this study were mecA positive (MRSA), which indicates
a high prevalence of MRSA strains among mastitic cows. This
finding coincided with Zutic et al. (2012) who indicated that
methicillin resistance is widely spread among S. aureus isolates
from bovine milk. Sharma et al. (2015) also found a high
prevalence of MRSA among bovines used for milk production
in India.
S. aureus isolates in the planktonic form were sensitive to
all the antibiotics used in the study, except for oxytetracycline
and penicillin. Similar results were reported for S. aureus iso-
lated from the milk of cows by Rajala-Schultz et al. (2004);
Wang et al. (2008); Coelho et al. (2009) and Bhatt et al. (2011).
They indicated that β-lactams (penicillins) and tetracycline are
widely used for intra-mammary treatment of staphylococcal
bovine mastitis. Not surprisingly then, these drugs are most
frequently associated with antimicrobial resistance. Costa et
al. (2000) also confirmed that S. aureus resistance to penicillin
and/or ampicillin was frequently observed (44.5%) in isolates
from both cows and heifers. Our results found S. aureus iso-
lates exhibiting high sensitivity to fluoroquinolones specially
enrofloxacin, which indicate these drugs may play an impor-
tant role for treatment of S. aureus infections in veterinary
medicine (Beco et al., 2013).
After evaluating the antibiotic susceptibility profile of S.
aureus isolates obtained from cows in our study, we next in-
vestigated the isolates’ ability to form biofilms. The MTP
method was employed as it has been reported to have high
specificity, sensitivity, and positive predictive values (Mathur
et al., 2006). Results of this study indicated that 10 (83.33%)
out of the 12 S. aureus isolates we investigated were capable
of forming biofilm using the MTP method. This finding was in
agreement with Darwish and Asfour (2013) who found that
96.3% of Staphylococcus spp. isolates were capable of forming
biofilms using the MTP method. Similarly, Schönborn et al.
(2017) found that 74.2% of S. aureus strains that caused mas-
titis were capable of producing biofilm. The remaining two iso-
lates from our study that did not form a biofilm, could be due
to the growth conditions used. S. aureus biofilm formation is
highly-sensitive to growth conditions, such as the amount of
glucose available for matrix formation (Cramton et al., 1999).
In addition, some capsular exopolysaccharides are not well ex-
pressed in the presence of oxygen (Gotz, 2002).Ta
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After confirming the ability of ten S. aureus isolates to form
biofilm, we investigated the susceptibility of these biofilms to
nine different antibiotics. All S. aureus isolates present within
the biofilm were resistant to all the antibiotics used in this
study. This most likely is an important factor that has con-
tributed to chronic and recurrent mastitis among the farm
cows that are resistant to antibiotic treatment. The ability of
S. aureus to form biofilms helps the bacterium to survive
within the host and is responsible for chronic or persistent in-
fections (Costerton et al., 1999). Biofilms facilitate the adher-
ence and colonization of bacteria onto the mammary gland
epithelium which leads to difficulty in eradicating the
pathogen (Zadoks et al., 2002; Vasudevan et al., 2003; Cu-
carella et al., 2004; Brouillette et al., 2005; Fox et al., 2005; Mel-
chior et al., 2006). Several studies showed that bacteria in
biofilms are 10 to 1000 times more resistant to the effects of
antibiotics as compared to the same strain in the planktonic
form (Amorena et al., 1999; Ceri et al., 1999; Mah and O’Toole,
2001; Olson et al., 2002; Conley et al., 2003). The production
of an exopolysaccharide matrix is one of the important char-
acteristics of biofilms. This matrix acts like a capsule that im-
pairs the access of antibiotics to bacterial cells (Stewart, 1996).
The slow growth of the bacteria in biofilms is also responsible
for the decreased susceptibility of bacteria to antibiotics that
require organisms to be actively growing/dividing. For exam-
ple, penicillins and cephalosporins are ineffective on non-
growing cells, and the rate of bacterial killing is proportional
to the growth rate (Costerton et al., 1999). Some antibiotics
like tetracyclines and erythromycin are not only less effective
against bacterial biofilms but may actually stimulate biofilm
formation (Melchior et al., 2006). Primary bacterial infections
usually consist of the invasive planktonic form of the bacteria,
whereas in chronic infections biofilms may be involved. Thus,
it is important to start early treatment when a rise in somatic
cell count indicates an intra-mammary subclinical infection
(De Haas et al., 2002). Early onset of treatment as well as pro-
longation of the treatment period both can be expected to
improve cure rates (Melchior et al., 2006).
Conclusion
This study found that S. aureus isolated from 12 bovine
clinical and subclinical mastitis cases carried the mecA gene
and were capable of producing biofilm. Moreover, isolates ca-
pable of forming biofilms were found to be resistant to most
of the antibiotics used in veterinary practice. Therefore, treat-
ing mastitic cows with antibiotics, on this particular farm, was
not a viable choice, and culling of these cases was suggested
as the best treatment option to protect the rest of the herd.
Treatment failure most likely was due to the formation of bac-
terial biofilms. Biofilms are difficult to eradicate, so in the fu-
ture the focus must be directed toward effective prophylaxis
and developing a suitable treatment regime.
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